Physician

Ady L. Djerassi

According to 2025 Medicare claims, Ady Djerassi (NPI: 1427076199) practices endocrinology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN INC (NPI: 1194207134; TIN: 831002191) and primary practice location at 19140-5103.

Djerassi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 184 traditional Medicare patients, billed 265 HCPCS/CPT codes, and received $18,750 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,724 prescription claims across 281 beneficiaries totaling $568,505 in drug costs, led by Ozempic (Semaglutide). DME data shows 119 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $11,512 and ending at $568,505. For DME billing, reported payments moved sharply higher in recent years, from $19,874 to $50,882.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	263	505	$28,081
2021	187	374	$19,373
2022	51	66	$6,833
2023	155	242	$19,772
2024	184	265	$18,750

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	53	$11,512
2016	N/R	42	$3,682
2017	N/R	34	$6,941
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	319	1,412	$446,988
2021	375	2,532	$804,483
2022	125	325	$109,227
2023	174	746	$354,039
2024	281	1,724	$568,505

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	57	132	$16,208
2021	80	376	$46,290
2022	26	111	$13,706
2023	36	194	$34,089
2024	39	119	$45,204

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	16	16	$106
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	38	38	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	99	135	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	13	29	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	31	32	$42

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	134	4,255	$134,488
Trulicity	Dulaglutide	111	3,838	$129,688
Jardiance	Empagliflozin	76	3,946	$74,790
Farxiga	Dapagliflozin Propanediol	33	2,070	$37,776
Fiasp Flextouch	Insulin Aspart (Niacinamide)	17	675	$17,791

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	28	90	$42,661
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	11	11	$2,239
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	18	$303

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Ady L. Djerassi?

Tedicare shows public-source Medicare data for Ady L. Djerassi (NPI 1427076199), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ady L. Djerassi have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ady L. Djerassi?

Ady L. Djerassi is linked to TEMPLE FACULTY PRACTICE PLAN INC (billing NPI 1194207134) in the available physician profile data.

Does Ady L. Djerassi have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.